As of 2025-05-31, the Intrinsic Value of Yifeng Pharmacy Chain Co Ltd (603939.SS) is 37.70 CNY. This 603939.SS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 26.06 CNY, the upside of Yifeng Pharmacy Chain Co Ltd is 44.70%.
The range of the Intrinsic Value is 26.06 - 62.63 CNY
Based on its market price of 26.06 CNY and our intrinsic valuation, Yifeng Pharmacy Chain Co Ltd (603939.SS) is undervalued by 44.70%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 26.06 - 62.63 | 37.70 | 44.7% |
| DCF (Growth 10y) | 57.56 - 125.26 | 79.23 | 204.0% |
| DCF (EBITDA 5y) | 51.47 - 96.56 | 74.19 | 184.7% |
| DCF (EBITDA 10y) | 74.87 - 137.37 | 105.15 | 303.5% |
| Fair Value | 30.88 - 30.88 | 30.88 | 18.51% |
| P/E | 25.95 - 29.60 | 26.78 | 2.8% |
| EV/EBITDA | 11.53 - 26.23 | 19.51 | -25.1% |
| EPV | 3.73 - 6.71 | 5.22 | -80.0% |
| DDM - Stable | 9.96 - 25.00 | 17.48 | -32.9% |
| DDM - Multi | 36.12 - 68.31 | 47.05 | 80.5% |
| Market Cap (mil) | 31,595.67 |
| Beta | 1.41 |
| Outstanding shares (mil) | 1,212.42 |
| Enterprise Value (mil) | 42,253.57 |
| Market risk premium | 6.13% |
| Cost of Equity | 9.89% |
| Cost of Debt | 5.00% |
| WACC | 8.12% |